Infectious Disease Expert Amesh Adalja and Epidemiologist Keri Althoff appear weekly on Bloomberg QuickTake's 'QuickTake Charge' to share their thoughts on the latest news and findings surrounding the COVID-19 pandemic in the U.S. and globally.
New segments with Amesh Adalja air live on Wednesdays at 9:15 a.m. EST. New segments with Keri Althoff air live on Fridays at 9:15 a.m. EST.
You can view our previous Bloomberg QuickTake segments below.
Astra-Oxford Vaccine Shot Gains UK Clearance
Amesh Adalja, MD, discusses the UK's recent approval of the AstraZeneca COVID-19 vaccine and when Americans could expect to see the shot roll out in the United States.
U.S. Orders 100 Million More Pfizer Shots
Amesh Adalja, MD, discusses his own experience with the coronavirus vaccine after receiving one himself, as well as how he plans to navigate the time between doses.
FDA Advisers Back EUA of Moderna Shot
Keri Althoff, Associate Professor of Epidemiology, discusses the latest news surrounding the Moderna vaccine and its quest for EUA approval, as well as when we can expect to see it rolled out in the U.S.
Second vaccine on its way to EUA
Amesh Adalja, MD, discusses what people should expect if there are two viable COVID-19 vaccines with emergency use authorizations.
FDA Vows Fast Pfizer Vaccine Action Amid Political Pressure
Keri Althoff, Associate Professor of Epidemiology, discusses the recent Food and Drug Administration's panel decision to support emergency use authorization of the Pfizer vaccine.
Global Covid-19 Cases Exceed 67 Million; Deaths Top 1.5 Million
Amesh Adalja, MD, discusses the latest with U.K.'s vaccine rollout plan and the hospitalization rates in the U.S.
CDC Shortens Quarantine Guidance to 10 Days for Those Exposed But Untested
Keri Althoff, Associate Professor of Epidemiology, discusses the revised CDC recommendations for quarantining after possible exposure to COVID-19.
U.K. Authorizes Pfizer and BioNTech’s Covid-19 Vaccine for Emergency Use
Amesh Adalja, MD, discusses the U.K.'s decision to approve a COVID-19 vaccine, with its regulator clearing Pfizer and BioNTech's shot ahead of decisions in the U.S. and European Union.
Post-Thanksgiving COVID Expectations & AstraZeneca Headed for Additional Trial
Keri Althoff, Associate Professor of Epidemiology, discusses latest news from the AstraZeneca vaccine trials, as well as what officials should expect after Thanksgiving travel and gatherings.
Experts Warn Holiday Travel Will Mean Surge in Cases, Takes a Toll on Everyone
Amesh Adalja, MD, discusses Thanksgiving travel during the COVID-19 pandemic and repercussions the U.S. may soon face after the holiday.
CDC Warns Thanksgiving Travel May Increase Covid Spread
Keri Althoff, Associate Professor of Epidemiology, discusses CDC guidelines for travel and holiday celebrations ahead of Thanksgiving, as well as the importance of mask-wearing.
U.S. Approves Covid-19 Self-Testing Kit
Amesh Adalja, MD, discusses the first COVID-19 diagnostic kit for self-testing at home and the importance of ramping up testing in general across the United States.
Azar Urges 'Extra Caution' During Thanksgiving, Christmas Gatherings
Keri Althoff, Associate Professor of Epidemiology, discusses safe holiday celebrations and traveling during the COVID-19 pandemic.
Global Virus Cases Surpass 51.5 Million, Deaths at 1.27 Million
Amesh Adalja, MD, Senior Scholar at the Johns Hopkins Center for Health Security, discusses the resurgence of coronavirus cases in the U.S. and globally, as well as the increasing number of deaths from the virus.
The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News. (Source: Bloomberg)